title: Features of rituximab-induced killing of B lymphocytes.
authors.forename: P
authors.initials: P
authors.lastname: Youinou
authors.forename: A
authors.initials: A
authors.lastname: Mankaï
authors.forename: A
authors.initials: A
authors.lastname: Bordron
authors.forename: C
authors.initials: C
authors.lastname: Berthou
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001402:B-Lymphocytes / Q000187:drug effects*; D006801:Humans; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab